LONDON - J.P. Morgan Securities PLC announced today that no stabilization actions were taken in connection with Nippon Life Insurance (NS:LIFI) Company's recent securities offering. The offering ...

Tokyo, Jan. 14 (Jiji Press)--The Japan Business Federation, or Keidanren, informally appointed Nippon Life Insurance Co. Chairman Yoshinobu Tsutsui as its next chairman on Tuesday to succeed ...

LONDON - J.P. Morgan Securities PLC announced today that it will coordinate the stabilization period for Nippon Life Insurance (NS:LIFI) Company's newly issued subordinated notes, starting Thursday.

LONDON - J.P. Morgan Securities PLC announced today that it will coordinate the stabilization period for Nippon Life Insurance (NS:LIFI) Company's newly issued subordinated notes, starting Thursday.

Huge final orders as company diversifies into euros ◆ Flat or negative concession offered ◆ Dollar and euro comparables used ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Nippon Life India Asset Management Ltd share price previously? Nippon Life India Asset Management Ltd share price ...

The bid by Japan's Nippon Steel to buy U.S. Steel may have a new lease on life, even as the potential for a new bid for the storied Pittsburgh steelmaker began to emerge Monday.

HARRISBURG, Pa. — The bid by Japan's Nippon Steel to buy U.S. Steel may have a new lease on life after the Biden Administration extended a deadline for the Japanese steelmaker to abandon plans ...

Regenxbio (RGNX) and Nippon Shinyaku announced a strategic partnership for the development and commercialization of RGX-121 for the treatment of Mucopolysaccharidosis II, or MPS II, also known as ...

Japan is known for its long life expectancy, but extending the period in which people are fully healthy is another important target. In 2022, “healthy life expectancy,” the period during which ...

Photo: Will Oliver - Pool via CNP/Zuma Press Nippon Steel and U.S. Steel last week filed a lawsuit against President Biden and the Committee on Foreign Investment in the United States (Cfius ...

(RTTNews) - REGENXBIO Inc. (RGNX) and Nippon Shinyaku announced a strategic partnership for the development and commercialization of RGX-121 for the treatment of Mucopolysaccharidosis II ...